The largest database of trusted experimental protocols

47 protocols using ultrasensitive mouse insulin elisa

1

Insulin Degradation Enzyme Inhibitor Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Various concentrations of IDE inhibitors were incubated with 1.5 µg/ml rhIDE for 1/2 h at RT. Next, recombinant human insulin (41-975-100, Biological Industries, Kibbutz Beit Haemek, Israel) diluted in Mercodia ultrasensitive mouse insulin ELISA (10-1249-01) calibrator 0 was added to the tubes and incubated for 1 h at 37°C. From each tube, 25 µl were taken and evaluated for residual insulin concentration using the Mercodia ultrasensitive mouse insulin ELISA kit. Absorbance at 450 nm was recorded by a Spectrafluor plus microplate reader (Tecan, Männedorf, Switzerland).
+ Open protocol
+ Expand
2

Quantifying Plasma and Colonic GLP-1 Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
For plasma GLP-1 quantification, blood samples were collected in test tubes containing a dipeptidyl peptidase IV inhibitor (Millipore). Colonic GLP-1 was extracted according to the method described by Cani et al.33 (link). The homogenate was centrifuged at 2000 × g for 20 min at 4 °C, and the supernatant fraction was decanted and diluted 1000-fold in assay buffer. The active GLP-1 concentration was determined using an enzyme-linked immunosorbent assay (ELISA) method (Active GLP-1 ELISA Kit, Shibayagi). Plasma and caecal acetate levels were enzymatically measured in duplicate using a commercial kit (Acetate Colorimetric Assay Kit, Sigma-Aldrich). The analysis of other caecal SCFAs was performed as follows: Caecal samples were suspended in 5% (w/v) metaphosphate-PBS (49 mL/g sample). Suspensions were subsequently filtered using a 3-kDa MWCO spin column (Pall Corporation) and analysed on a gas chromatography-flame ionisation detector system (Shimadzu GC2014, Shimadzu, Kyoto, Japan) equipped with a glass column packed with 60/80 SHINCARBON A coated with Themon-3000 (Shinwa-kakou). Plasma triglyceride (Wako) and insulin (Ultrasensitive Mouse Insulin ELISA, Mercodia) levels were determined using the corresponding commercial kits.
+ Open protocol
+ Expand
3

Quantifying Metabolic Biomarkers in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood glucose levels were quantified after 6 h of fasting using a OneTouch Vita® meter (Lifescan). Plasma Human alpha-synuclein levels were measured using the Human alpha-Synuclein Kit (Meso Scale Discovery) according to the manufacturer’s instructions. Intraassay coefficient of variation was < 14%. Plasma insulin was assayed using the Mercodia Ultrasensitive Mouse Insulin ELISA (Mercodia). Intra- and interassay coefficients of variation were <3.4 and <3.0%, respectively. Plasma leptin was measured using the Quantikine® ELISA kit (R&D Systems). Intra- and interassay coefficients of variation were <4.5 and <4.7%, respectively. All the samples were analyzed in duplicate.
+ Open protocol
+ Expand
4

Pancreatic Insulin Quantification Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pancreatic insulin content was determined from 3- and 10-week age- and sex-matched animals. Snap-frozen pancreata were weighed and insulin was extracted with cold acid-ethanol. Briefly, pancreata were incubated O/N in acid-EtOH (1.5% HCl in 70% ethanol) at −20 °C, and then homogenized and incubated O/N at −20 °C. Samples were centrifuged 15 min 2000 r.p.m. at 4 °C and supernatant removed and neutralized with 1 : 1 volume TRIS (1M pH7.5). Insulin content in acid-ethanol supernatant was determined with Ultrasensitive Mouse Insulin ELISA (Mercodia AB, Uppsala, Sweden).
+ Open protocol
+ Expand
5

Glucose Tolerance and Insulin Release

Check if the same lab product or an alternative is used in the 5 most similar protocols
Age- and sex-matched mice aged 3, 6 and 10 weeks were fasted overnight for ~16 h, weighed and subsequently injected intraperitoneally with glucose (2 g/kg body weight). For glucose tolerance tests, blood glucose levels were measured at 0, 30, 60, 90 and 120 min post injection from tail vein blood as described above. For insulin release studies, blood was collected at 0 and 15 min post injection. Serum insulin levels were measured with Ultrasensitive Mouse Insulin ELISA (Mercodia AB). All procedures were carried out in a blinded manner.
+ Open protocol
+ Expand
6

Insulin Release Measurement via ipGTT

Check if the same lab product or an alternative is used in the 5 most similar protocols
For insulin release studies, measurement of serum insulin concentration during Intraperitoneal glucose tolerance test (ipGTT) was performed by blood collection at 0 and 15 min post injection using a Microvette 200 Z-Gel (Sarstedt, Hildesheim, Germany), followed by centrifugation for serum separation and analysis. Samples were stored at −80 °C before measurement for insulin levels. Serum insulin levels were measured with Ultrasensitive Mouse Insulin ELISA (Mercodia AB).
+ Open protocol
+ Expand
7

Intravenous Substrate Infusion Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
To enable i.v. substrate infusion, a permanent silicone catheter was inserted into the left jugular vein under ketamine/xylazine anesthesia. For matching body fat and fat-free mass, mice were subjected to 1H-NMR analysis (MiniSpec, Bruker Optics Inc, Ettlingen, Germany) 6 days later. On the morning of the seventh postsurgical day, conscious mice were placed in restrainers (Opti-Lab, Munich, Germany) set on top of heating pads. The subcutaneously located catheter end, accessible via attached silk protruding from a small interscapular skin incision, was connected to 1cc syringes fastened in a microdialysis pump (CMA 402, Solna, Sweden). For immediate measurement of plasma glucose concentrations (Glucometer Ascensia Elite, Bayer, Leverkusen, Germany), tail-tip blood samples were collected in heparinized CB300 LH Microvettes. Plasma insulin concentrations were measured via an Ultrasensitive Mouse Insulin ELISA (Mercodia, cat#10-1249-01).
+ Open protocol
+ Expand
8

Serum Insulin, C-Peptide, and Glucagon Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
All measurements were carried out on animals of 2–6 months of age. Mice were fasted 18 hours before blood and serum collection. Blood samples were collected from the tail vein, and glucose concentration was determined using a Glucotrend 2 kit (Roche). Serum was obtained after clotting, and separation was obtained by centrifugation. Quantification was performed with a solid-phase, two-site ELISA immunoassay specific for mouse insulin (Ultrasensitive mouse insulin ELISA, Mercodia, Cat No 10-1247-01), c-peptide (c-peptide ELISA, Mercodia, Cat No 10-1172-01) and glucagon (Glucagon ELISA, Mercodia Cat No 10-1271-01). Assays for each serum were performed in duplicate.
+ Open protocol
+ Expand
9

Comprehensive Molecular Analysis of Insulin and Rhodopsin Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The reagents used for different parts of this work were obtained from the indicated suppliers as follows: RNAProtect cell reagent (QIAGEN, 76526), NucleoSpin RNA isolation kit (Macherey Nagel, 740955), Quanti-Tect reverse transcription kit (QIAGEN, 205313) and Taqman probes (Thermo Fisher): Ins2 (Mm00731595_gH), Mer (Mm00434920_m1), rhodopsin (Mm01184405_m1) and Ins1 (Mm01950294_s1). Antibodies used were anti-insulin (Agilent, IR002), anti-insulin (Cell Signaling, 3014), anti-C-peptide (Phoenix Pharmaceuticals, H-035-03), anti-Cre recombinase (Millipore, MAB3120), anti-rhodopsin (Abcam, ab98887), anti-cone arrestin (Millipore, AB15282), anti-phospho insulin receptor-β (Tyr1150/1151) (19H7) (Cell Signaling, 3024), anti-insulin receptor-β (Novus Biologicals, NBP2 12793), anti-Glut4 (Alomone Labs, AGT 024), anti-β actin HRP (Sigma, A3854) and anti-rabbit IgG HRP (GE Healthcare, NA934V). We also used Halt Phosphatase inhibitor (Thermo Fisher, 1862495), Halt Protease inhibitor (Thermo Fisher, 1862209), ultrasensitive mouse insulin ELISA (Mercodia, 10-1249-01), mouse C-peptide ELISA (CrystalChem, 90050), rat/mouse C-peptide 2 ELISA (Millipore, EZRMCP2), glucose Glo Assay (Promega, J602), lactate Glo Assay (Promega, J5021) and eBioscience Foxp3 Transcription Factor Staining Buffer Set (Thermo Fisher, 00-5523-00).
+ Open protocol
+ Expand
10

Insulin and C-peptide ELISA Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein isolates from RPE were obtained as previously described51 (link). Insulin ELISA was performed per manufacturer’s instructions using Ultrasensitive Mouse Insulin ELISA (Mercodia). C-peptide ELISA was performed as per manufacturer’s instructions using the Mouse C-peptide (CrytalChem) and Rat/Mouse C-peptide 2 (Millipore) ELISA kits.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!